Overcoming HER2 /estrogen receptor (ER) crosstalk: Neratinib ± dulvestrant in ER+HER2-mutant metastatic breast cancer (MBC) in the phase II summit trial Meeting Abstract

  

Authors:	Beer, H.; Cutler, R.; Piha-Paul, S.; Saura, C.; Lalani, A.; Hyman, D.
Abstract Title:	Overcoming HER2 /estrogen receptor (ER) crosstalk: Neratinib ± dulvestrant in ER+HER2-mutant metastatic breast cancer (MBC) in the phase II summit trial
Meeting Title:	42nd Annual Congress of the Oncology Nursing Society (ONS)
Journal Title:	Oncology Nursing Forum
Volume:	44
Issue:	2
Meeting Dates:	2017 May 4-7
Meeting Location:	Denver, CO
ISSN:	0190-535X
Publisher:	Oncology Nursing Society (ONS)
Date Published:	2017-02-01
Start Page:	208
Language:	English
ACCESSION:	WOS:000401160800581
PROVIDER:	wos
DOI:	10.1188/17.ONF.E88
Notes:	Meeting Abstract: IS-4 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/111070